Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2005-1-17
pubmed:abstractText
The authors studied the clinical outcome of 106 children with acute lymphoblastic leukemia (ALL) who developed a bone marrow recurrence as the first adverse event after contemporary intensified therapy.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0008-543X
pubmed:author
pubmed:copyrightInfo
(c) 2004 American Cancer Society.
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
103
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
368-76
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:15599932-Adolescent, pubmed-meshheading:15599932-Age Distribution, pubmed-meshheading:15599932-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15599932-Blast Crisis, pubmed-meshheading:15599932-Bone Marrow, pubmed-meshheading:15599932-Child, pubmed-meshheading:15599932-Child, Preschool, pubmed-meshheading:15599932-Cohort Studies, pubmed-meshheading:15599932-Disease-Free Survival, pubmed-meshheading:15599932-Dose-Response Relationship, Drug, pubmed-meshheading:15599932-Female, pubmed-meshheading:15599932-Humans, pubmed-meshheading:15599932-Incidence, pubmed-meshheading:15599932-Male, pubmed-meshheading:15599932-Neoplasm Recurrence, Local, pubmed-meshheading:15599932-Precursor Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:15599932-Probability, pubmed-meshheading:15599932-Prognosis, pubmed-meshheading:15599932-Proportional Hazards Models, pubmed-meshheading:15599932-Remission Induction, pubmed-meshheading:15599932-Retrospective Studies, pubmed-meshheading:15599932-Risk Assessment, pubmed-meshheading:15599932-Severity of Illness Index, pubmed-meshheading:15599932-Sex Distribution, pubmed-meshheading:15599932-Survival Rate
pubmed:year
2005
pubmed:articleTitle
Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
pubmed:affiliation
Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. gaston.rivera@stjude.org
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't